Compare MRNA & DRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MRNA | DRI |
|---|---|---|
| Founded | 2010 | 1968 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Restaurants |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 26.7B | 22.2B |
| IPO Year | 2018 | 2000 |
| Metric | MRNA | DRI |
|---|---|---|
| Price | $72.47 | $202.12 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 12 | 25 |
| Target Price | $34.27 | ★ $226.50 |
| AVG Volume (30 Days) | ★ 7.6M | 1.4M |
| Earning Date | 05-01-2026 | 03-19-2026 |
| Dividend Yield | N/A | ★ 3.06% |
| EPS Growth | ★ 21.77 | 4.11 |
| EPS | N/A | ★ 6.87 |
| Revenue | ★ $19,263,000,000.00 | $12,076,700,000.00 |
| Revenue This Year | $9.36 | $10.58 |
| Revenue Next Year | $15.43 | $3.73 |
| P/E Ratio | ★ N/A | $29.94 |
| Revenue Growth | 4.29 | ★ 6.03 |
| 52 Week Low | $22.28 | $169.00 |
| 52 Week High | $73.28 | $220.85 |
| Indicator | MRNA | DRI |
|---|---|---|
| Relative Strength Index (RSI) | 74.31 | 45.29 |
| Support Level | $45.69 | $187.10 |
| Resistance Level | N/A | $203.71 |
| Average True Range (ATR) | 5.14 | 6.08 |
| MACD | 1.66 | -0.93 |
| Stochastic Oscillator | 92.36 | 1.52 |
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
Darden Restaurants is the largest global full-service dining operator, with over $12 billion in system sales across 2,159 company-owned stores at the end of fiscal 2025, spanning the US and Canada. The firm operates 10 banners in four segments, including Olive Garden (43% of sales), LongHorn Steakhouse (25%), and fine dining (21%), which includes The Capital Grille, Ruth's Chris, and Eddie V's. The other 11% of sales comes from smaller concepts such as Yard House and Cheddar's. Darden primarily generates revenue through sales of food and beverage items at its company-owned restaurants. It also earns royalties on sales from 154 franchised locations in US and international markets, which sit within the other segment but are immaterial to consolidated results.